i figure a small parcel making up 1-2% of my portfolio its a good punt:
- its got a beaten down sp
- a positive catalyst due shortly in the ce mark
- genuinely innovative product in an area of need
- good preliminary data
- phase 2 studies starting shortly
- strong institutional affiliations in usa/ uk
worse case scenario, it doesnt get the ce mark yet and drops a few more cents
best case, its the next sirtex (long shot but not out of the question) or a takeover target for a bigger biotech/ pharma
i figure a small parcel making up 1-2% of my portfolio its a...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(10.0%) |
Mkt cap ! $18.32M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $2.272K | 434.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4804961 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 17266541 | 20 |
View Market Depth
| Last trade - 12.51pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.001 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.5¢ | 444513 | ||
| Last updated 13.41pm 07/06/2024 ? | |||||
| OSL (ASX) Chart |